Skip to main content
. 2020 May 17;10(15):6629–6637. doi: 10.7150/thno.47849

Figure 1.

Figure 1

Schematic illustration showing the drug delivery process of ZTC-NMs. (A) The PCB-like zwitterion-modified nanomedicine shows high stability in blood circulation, resulting in efficient tumor accumulation through the EPR effect. (B) In tumor acidic microenvironment, the acid-induced zwitterionic-to-cationic surface charge conversion leads to enhanced cellular internalization of the nanomedicine. (C) The high level of intracellular GSH permits triggered drug release.